-
Global Intranasal Drug and Vaccine Delivery Market Report 2022: Rising Prevalence of Respiratory and Neurological Diseases Fuels Growth - ResearchAndMarkets.com
22 Nov 2022 16:46 GMT
… of Prescriptions for Non-invasive Drug Delivery Routes
Improving Healthcare Infrastructure …
Market Segmentations
The Global Intranasal Drug and Vaccine Delivery Market is …
Johnson & Johnson Services, Inc.
Marina Biotech, Inc.
Merck & Co.
Neurelis …
-
Global Intranasal Drug & Vaccine Delivery Market Research Report to 2027 - Rise in Number of Prescriptions for Non-invasive Drug Delivery Routes Presents Opportunities - ResearchAndMarkets.com
19 May 2022 09:48 GMT
… of prescriptions for non-invasive drug delivery routes
Improving healthcare … Technological advancements related to nasal drug delivery systems
Challenges
Development challenges …
Johnson & Johnson Services Inc
Marina Biotech, Inc.
Merck & Co.
…
-
Intranasal Drug & Vaccine Delivery Market Research Report by Distribution Channel, by Application, by Product, by Dosage, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
15 Feb 2022 15:27 GMT
… report categorizes the Intranasal Drug & Vaccine Delivery … in the Global Intranasal Drug & Vaccine Delivery Market … Johnson & Johnson Services Inc, Marina Biotech, Inc., Merck & Co … in the Global Intranasal Drug & Vaccine Delivery Market …
-
Angiotensin Converting Enzyme (ACE) Inhibitor Drug Pipeline Market Research Report 2022 - ResearchAndMarkets.com
14 Feb 2022 16:16 GMT
… including (but not limited to) drug description, product development and R … ;discontinuation
Companies Mentioned
Gene PreDiT
Marina Biotech
Proveca
Daewon Pharmaceutical
Ethicare GmbH …
-
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
03 Oct 2018 12:00 GMT
… of fixed-dose combination hypertensive drugs such as PRESTALIA® (perindopril arginine … amlodipine besylate) and such other drugs as may enter our pipeline … DyrctAxess platform. Additional information about Marina Biotech is available at http:…
-
Marina Biotech Appoints Eric Teague as Chief Financial Officer
24 Sep 2018 12:00 GMT
… . Moscato and will oversee Marina Biotech’s finance, accounting, financial … leveraging technology and proven drug therapies to disrupt traditional … fixed dose combination hypertensive drugs such as Prestalia and … other drugs in our pipeline. …
-
Marina Biotech Inc. Raises $1.5 Million
25 Jul 2018 22:35 GMT
… New Beachhead for Biotech"
Marina Biotech executives said they would employ … market the company’s Prestalia drug to treat hypertension, along … Pfizer Inc., with a proprietary drug – could be approved by … U.S. Food and Drug Administration by as early 2019 …
-
Myotonic Dystrophy Drug Market Size Forecast 2021: Future Trends, Emerging Technologies, Global Regions with Industry Share Analysis, Industry Trends Forecast to 2027
07 May 2021 06:47 GMT
… opportunities. The Myotonic Dystrophy Drug market report gives comprehensive … Genzyme Corporation
● Isis Pharmaceuticals, Inc.
● Marina Biotech, Inc.
● Valentia Biopharma S.L … Detailed overview of Myotonic Dystrophy Drug Market Trends
● Changing market …
-
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
20 Jun 2018 15:46 GMT
… GLOBE NEWSWIRE via COMTEX) -- Marina Biotech, Inc. (otcqb:MRNA), … fixed dose combination hypertensive drugs such as Prestalia and … other drugs in our pipeline. The … epidemic. Additional information about Marina Biotech is available at http:…
-
Windlas Healthcare Invests $2 Million in Working Capital to Support Marina Biotech’s Manufacturing Initiatives
21 Aug 2017 12:30 GMT
… www.windlashealthcare.com. About Marina Biotech, Inc.
Marina Biotech's focus … therapies of already approved drugs. Marina’s first FDA … likely to need multiple drugs to achieve blood pressure … patients already taking both drugs. Exploiting the suppression of …